Nociceptive vs. neuropathic pain: Physiological regulating medicine (PRM)/new approach for its control;Dolor nociceptivo vs. neuropático: Medicina fisiológica de regulación (FMR)/ nuevo enfoque para su control

Dolor, Clinica y Terapia

Volumn 5, Issue 10, 2008, Pages 17-22

  Urgellés Lorié, Luis A ^a,b,c  

^a Instituto de Neurología Neurocirugía Y Psiquiatría   (Bulgaria)

^b Instituto de Medicina Tradicional de Hanoi Y Saigón   (Viet Nam)

^c MDC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 68249144432     PISSN: None     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. Trillo RC, et al. Dolor y Sistema Inmune Boletín del Dolor-ASPED, Perú julio-diciembre, 2001.
2. Bastida DA. Neuroendocrino-inmunological connections. Rev Mex Patol Clin 2002; 49 (2): 85-91.
3. Urgellés Lorié LA. Dolor nociceptivo vs. neuropático. La medicina fisiológica de regulación: una nueva alternativa. Material de Conferencias. US National Tour (Puerto Rico, Ecuador, México). Enero-febrero, 2008.
4. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature New Biol 1971:231;232-235.
5. Lichtenberger LM, Vane JR, et al. Selectivity of non-steroidal anti-inflammatory drugs as inhibitor of constitutive and inducible cyclooxigenase. Pro Natl Acad Sci 1994: 90; 11693-11697. (Pubitemid 24008705)
6. Donnelly MT, Hawkey CJ. Review article: COX-II inhibitor-a new generation of safer NSAIDs? Aliment Pharmacol Ther, 1997:11; 227-236.
7. Urgellés Lorié LA, Cifuentes LF. Celebrex (celecoxib). Analgésico del milenio. J. de Clínica en Odontología 2002; 17(2)105-109.
8. Samad TA, et al. Interleukin-1 beta-mediated induction of COX-2 in CNS contributes to inflammatory pain hypersensitivity. Nature 2001; 410: 471-475. (Pubitemid 32240046)
9. Bianchi I. Th1/Th2 balance diluted and potentized cytokines: the rol of physiological regulating medicine in inmunoregulation. Loyola University. Chicago, USA. Nov. 2007.
10. Kuritzky L, Samraj G. Current treatments in the management of diabetic peripheral neuropatic pain. Pain Medicine News 2007; nov. 5 (6):11-20.
11. Gupta K. Prevalence, diagnosis and management of fibromialgia. Medicine News 2007; nov. 5 (6):32-36.
12. Ventafrida V, et al. A validation study of the WHO method for cancer pain. Relief Cancer 1987; 59:851-856.
13. Ventafrida V. Continuing care: a major issue in cancer pain management. Pain 1989; 36:137-143.
14. Urgellés Lorié LA. La clínica del dolor en oncología: un objetivo inmediato. Rev Cub Oncol 1989; 5 (1-2): 51-64.
15. Urgellés Lorié LA. Dolor y cáncer. Rev Selecta Médica. Bogotá, Colombia, 1998; 9(3):25-26.
16. Russell KP. Three-step analgesic ladder for management of cancer pain. Medicine News, 2007; vov. 5 (6): 81-91.
17. Urgellés Lorié LA. Acupuntura en la sacrolumbalgia. Rev Hos Psq 1983; 24 (3): 429.
18. Melzack K, Wall P. Pain mechanism: a new theory. Science 1965; 150: 971-979.
19. Urgellés Lorié LA. Acupuntura para el manejo del dolor. Ed. AMOLCA, Venezuela, 2002.
20. Milani L. Homeomesotherapy for pain management in primary chronic coxarthrosis with homeophatic injectable formulation PRM. Medical Journal of Homeophatic, Homotoxicology and Integrative Medicine 2006;1:9-18.
21. Milani L. Inflammation and physiological regulating medicine: new ideas and innovative medical products. Physiological regulating medicine. Medical Journal of Homeopathy, Homotoxicology and Integrative Medicine 2007; 1:19-27.